{"id":68123,"url":"https://lda.senate.gov/api/v1/clients/68123/?format=json","client_id":68123,"name":"KEDRION BIOPHARMA","general_description":"Production of Plasma-Derived Therapies","client_government_entity":null,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-04-11","registrant":{"id":400532589,"url":"https://lda.senate.gov/api/v1/registrants/400532589/?format=json","house_registrant_id":null,"name":"PRIME POLICY GROUP","description":"Government relations","address_1":"1801 K Street NW","address_2":"Suite 9000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ABBI SOTHMANN","contact_telephone":"+1 202-530-4574","dt_updated":"2026-01-29T20:20:14.632389-05:00"}}